Post by account_disabled on Dec 21, 2023 4:13:06 GMT
Health District Office 9, Ministry of Public Health Suranaree University of Technology and Novartis (Thailand) signed a cooperation agreement to manage risk factors. on the occurrence of cardiovascular disease Bangkok, 6 September 2022 – Dr. Phongkasem Kaimuk (center), Inspector General of the Ministry of Public Health, Health Zone 9, Associate Professor Dr. Anan Thongra-a (3rd from left), President of Suranaree University of Technology and Dr. Samrerng Haengkratok (2nd from left), Chairman of the People's Health District Committee, District 9, signed a cooperation agreement to integrate the management of risk factors for cardiovascular disease.
Together with Novartis (Thailand) Company Limited, a world-leading Email Data pharmaceutical and medical supply company. Led by pharmacist Sumalee Kristhanin (5th from left), Chairman of the Board of Directors, and Mr. Raiyan Jerome Slater (far right), Country Head of Pharma, this cooperation agreement was signed to deal with disease problems. The heart and blood vessels are the top causes. of premature death of the population This cooperation focuses on driving the process of prevention and control of cardiovascular disease in a sustainable, concrete, and holistic manner covering all dimensions. From promoting screening, diagnosis, monitoring, to access to innovative and effective treatments, the ceremony was held at.
the Center Point Hotelant Thongra-a, President of Suranaree University of vartis (Thailand) Company Limited, Dr. Atchara Nithipinyasakul Public Health Supervisor and Director of Health Region 9, Mr. Ryan Girome Slatter, Country Head of Pharma, Novartis (Thailand) Co., Ltd. About Novartis (Thailand) Co., Ltd. Novarti S (Thailand) Co., Ltd. is a leading pharmaceutical company. Headquartered in Basel. Switzerland The company was registered in Thailand in 1971, operating the business of importing and distributing pharmaceuticals. With over 50 years of consistent quality standards, the company continues to focus on building partnerships with various sectors to develop innovative treatments to provide patients with better treatment.
Together with Novartis (Thailand) Company Limited, a world-leading Email Data pharmaceutical and medical supply company. Led by pharmacist Sumalee Kristhanin (5th from left), Chairman of the Board of Directors, and Mr. Raiyan Jerome Slater (far right), Country Head of Pharma, this cooperation agreement was signed to deal with disease problems. The heart and blood vessels are the top causes. of premature death of the population This cooperation focuses on driving the process of prevention and control of cardiovascular disease in a sustainable, concrete, and holistic manner covering all dimensions. From promoting screening, diagnosis, monitoring, to access to innovative and effective treatments, the ceremony was held at.
the Center Point Hotelant Thongra-a, President of Suranaree University of vartis (Thailand) Company Limited, Dr. Atchara Nithipinyasakul Public Health Supervisor and Director of Health Region 9, Mr. Ryan Girome Slatter, Country Head of Pharma, Novartis (Thailand) Co., Ltd. About Novartis (Thailand) Co., Ltd. Novarti S (Thailand) Co., Ltd. is a leading pharmaceutical company. Headquartered in Basel. Switzerland The company was registered in Thailand in 1971, operating the business of importing and distributing pharmaceuticals. With over 50 years of consistent quality standards, the company continues to focus on building partnerships with various sectors to develop innovative treatments to provide patients with better treatment.